SU502605A3 - Method for preparing imidazole derivatives - Google Patents
Method for preparing imidazole derivativesInfo
- Publication number
- SU502605A3 SU502605A3 SU1971711A SU1971711A SU502605A3 SU 502605 A3 SU502605 A3 SU 502605A3 SU 1971711 A SU1971711 A SU 1971711A SU 1971711 A SU1971711 A SU 1971711A SU 502605 A3 SU502605 A3 SU 502605A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- phenyl
- substituted
- lower alkyl
- halogen
- hydroxy
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 4
- 150000002460 imidazoles Chemical class 0.000 title claims 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title claims 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- -1 methoxy- Chemical group 0.000 claims description 6
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 3
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 150000001204 N-oxides Chemical class 0.000 claims 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims 2
- 125000004414 alkyl thio group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- WXGQWNXTPSGPIX-UHFFFAOYSA-N O-Methylmoschatoline Natural products C1=CC2=C(OC)C(OC)=C(OC)C(C=3C(=CC=CC=3)C3=O)=C2C3=N1 WXGQWNXTPSGPIX-UHFFFAOYSA-N 0.000 claims 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Chemical group 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229960001866 silicon dioxide Drugs 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 2
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- XSOGGPTVKLKMAW-UHFFFAOYSA-N 1-phenyl-2-pyridin-3-ylethane-1,2-dione Chemical compound C=1C=CC=CC=1C(=O)C(=O)C1=CC=CN=C1 XSOGGPTVKLKMAW-UHFFFAOYSA-N 0.000 description 1
- HYWUIJBSMIDLIJ-UHFFFAOYSA-N 1h-imidazol-2-ylmethanesulfonic acid Chemical compound OS(=O)(=O)CC1=NC=CN1 HYWUIJBSMIDLIJ-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- KHIWOFSLCFBXLV-UHFFFAOYSA-N 2-hydroxy-1-phenyl-2-pyridin-3-ylethanone Chemical compound C=1C=CN=CC=1C(O)C(=O)C1=CC=CC=C1 KHIWOFSLCFBXLV-UHFFFAOYSA-N 0.000 description 1
- RDXUXWYWABYPJH-UHFFFAOYSA-N 2-tert-butyl-4-phenyl-5-pyridin-3-yl-1,3-oxazole Chemical compound C(C)(C)(C)C=1OC(=C(N=1)C1=CC=CC=C1)C=1C=NC=CC=1 RDXUXWYWABYPJH-UHFFFAOYSA-N 0.000 description 1
- CEOUDUCITJEQQT-UHFFFAOYSA-N 3-(2-tert-butyl-5-phenyl-1h-imidazol-4-yl)pyridine Chemical compound N1C(C(C)(C)C)=NC(C=2C=NC=CC=2)=C1C1=CC=CC=C1 CEOUDUCITJEQQT-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- CRZQGDNQQAALAY-UHFFFAOYSA-N Methyl benzeneacetate Chemical compound COC(=O)CC1=CC=CC=C1 CRZQGDNQQAALAY-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- OAMZXMDZZWGPMH-UHFFFAOYSA-N ethyl acetate;toluene Chemical compound CCOC(C)=O.CC1=CC=CC=C1 OAMZXMDZZWGPMH-UHFFFAOYSA-N 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 150000002916 oxazoles Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 229940086542 triethylamine Drugs 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
солью низшей алкановой кислоты, например кин т т с обратным холодильником с избытком а|цетата аммони в лед ной уксусной кислоте. При этом образуетс соответствующий оксазол.a salt of a lower alkanoic acid, for example, is refluxed with an excess of ammonium acetate in glacial acetic acid. A corresponding oxazole is formed.
По другому способу оксазолы получают дегидратацией амида общей формулыIn another way, oxazoles are obtained by dehydrating the amide of the general formula
в,-со со-к,in, -co-to,
i i
Bj-CH-TJfiBj-ch-tjfi
где Ri, RS и Нз имеют указанные выше значени , ,на:иример кип чением с тионилхлоридом в Присутствии .или в отсутствии инертного растворител , например бензола, до прекращени образовани хлористого водорода, или обработкой коБцентрировалной серной кислотой При температуре от 0° С до комнатной.where Ri, RS and Hz are as defined above,, on: irimer by boiling with thionyl chloride in the Presence. or in the absence of an inert solvent, for example benzene, until hydrogen chloride ceases to form, or by treatment with co-concentrated sulfuric acid At 0 ° C to room temperature .
Пример, а) Бензил-(З-пиридил)-кетон.Example, a) Benzyl- (Z-pyridyl) -keton.
К смеси 27,4 г (0,2 лголь) сложного метилового эфира никотиновой кислоты и 30 г (0,2 моль} сложного метилового эфира фенилуксусной кислоты прибавл ют по порци м при 20-25° С в атмосфере азота 16,2 г (0,3 моль} метилата натри . Реакционную с.месь перемешивают 20 час при С, причем слабым потоком азота отдувают образующийс спирт. Затем к твердой массе прикалывают 60 мл концентрированной сол ной кислоты и 1КИ1ПЯТЯТ 3 час с обратным .холодильнико .м. К еще гор чему желтому раствору приливают 30 мл воды и охлаждают до 50° С. Далее прибавл ют 60 мл хлороформа и реакционную смесь о.хлаждают до 5° С. О бразовавшиес белые кристаллы фильтруют на нутчфильтре и промывают хлороформом. Тем1пература ллавлени кристаллов 225° С (из этанола).To a mixture of 27.4 g (0.2 lgol) of nicotinic acid methyl ester and 30 g (0.2 mol) of phenylacetic acid methyl ester is added in portions at 20-25 ° C under a nitrogen atmosphere of 16.2 g ( 0.3 mol of sodium methoxide. The reaction mixture is stirred at C for 20 hours, the resulting alcohol is blown off with a weak stream of nitrogen, and then 60 ml of concentrated hydrochloric acid is poured onto the solid mass and rinsed 3 hours in reverse with a cold refrigerant. 30 ml of water are poured into the hot yellow solution and cooled to 50 ° C. Then 60 ml of chloroform are added and the reaction the ionic mixture is cooled to 5 ° C. The white crystals formed are filtered on a suction filter and washed with chloroform. The temperature of crystal melting is 225 ° C (from ethanol).
б) 1-Фенил-2- (3-,пиридил) -глиоксаль.b) 1-Phenyl-2- (3-, pyridyl) -glyoxal.
23,4 г (0,1 моль} бензил-(3-пиридил)-:кетан-ги дрохлорида распвор ют в 180 мл диметилсульфоксида и приливают 20 мл 48%-ной бромистоводородной -кислоты. Реакционную смесь перемешивают 18 час при 80-85° С и затем выливают в смесь 800 г льда и 1000 .ил ВОДЫ. Желтую эмульсию экстрагируют дважды, примен по 200 мл этил ацетата . Обе органические фазы объедин ют, промьиают водой и .высушивают над сульфатом натри . Красный раствор концентрируют в ротаи.ионном (ВЫпарном аппарате до -получени в качестве остатка 1масла, которое перегон ют в трубке с шаровым расширением при 140-150° С/0,1 мм рт. ст. Температура пллзлени -полученного соэдинени 56-57° С.23.4 g (0.1 mol) of benzyl- (3-pyridyl) -: ketan-gi drochloride are dissolved in 180 ml of dimethyl sulfoxide and 20 ml of 48% hydrobromic acid are poured in. The reaction mixture is stirred for 18 hours at 80-85 ° C and then poured into a mixture of 800 g of ice and 1000. WATER.The yellow emulsion is extracted twice with 200 ml of ethyl acetate. Both organic phases are combined, washed with water and dried over sodium sulfate. The red solution is concentrated in a rotated (A boiling kettle prior to receiving as a residue 1 oil that is distilled in a tube with ball expansion m at 140-150 ° C / 0.1 mm Hg. v. Temperature pllzleni -Getting soedineni 56-57 ° C.
|з) 2-Окси-2-(З-юиридил)-ащетофенон.| h) 2-Oxy-2- (Z-yuridil) -shastofenon.
К раствору 1,2,6 г (60 ммоль) 1-фенил-2 (З-пиридил)-глиоксал в 180 абсолютного метанола Пр.Ибавл ют по лорци м при перемэшива:нии , при 3-6° С в течение 30 мин 970 мг (17,34 ммоль) бортидрида кали . Реакционный раствор леремешввают 40 мин при С, прибавл ют 50 г льда, 100 мл 5 л. сол ной кислоты и отгон ют в вакууме метанол . К оставшемус желтому .водному раствору прибавл ют 100 г льда и 300 мл 2 и. раствора карбоната натри и экстрагируют этилацетатом . Органическую фазу промывают насыщенным раствором хлорида натри , сушат над сульфатом «атри и выпаривают, причем остаетс 2-окси-2-(3-пиридил)-ацетофенон в виде масла.To a solution of 1.2.6 g (60 mmol) of 1-phenyl-2 (3-pyridyl) -glyoxal in 180 of absolute methanol Ex. Add in portions during peremeshiva: at 3-6 ° C for 30 minutes 970 mg (17.34 mmol) potassium bortirid. The reaction solution was stirred for 40 minutes at C, 50 g of ice, 100 ml 5 l were added. hydrochloric acid and methanol is distilled off in vacuo. To the remaining yellow aqueous solution is added 100 g of ice and 300 ml 2 and. sodium carbonate solution and extracted with ethyl acetate. The organic phase is washed with a saturated solution of sodium chloride, dried over atrium sulphate and evaporated, leaving 2-hydroxy-2- (3-pyridyl) -acetophenone as an oil.
г)2-ПивалоилоКси-2-(3-:Пиридил) - ацетофенол .d) 2-Pivaloyloxy-2- (3-: Pyridyl) - acetophenol.
К смеси 3,5 г (16,4 ммоль) 2-окси-2-(3-пирид .ил)-ацетофе.нона, 2,7 мл трИэтиламина и 40 мл абсолютного бензола прикапывают при 22° С (начальной температуре) раствор 2,91 аTo a mixture of 3.5 g (16.4 mmol) of 2-hydroxy-2- (3-pyrid. Yl) acetophe. Non, 2.7 ml of tri-ethylamine and 40 ml of absolute benzene was added dropwise at 22 ° C (initial temperature) solution 2.91 a
(27 ммоль) хлорангидрида пивалиновой кислоты в 15 мл абсолютного бензола. Прл этом тэм1пература ловышаетс до 30°С.. Суслензию перемешивают 4 час при 40° С, приливают 50 мл воды и (Перемешивают 0,5 час(27 mmol) of pivalic acid chloride in 15 ml of absolute benzene. The temperature is below 30 ° C. The suction is stirred for 4 hours at 40 ° C, 50 ml of water are poured and (Stir for 0.5 hour
при 20-25° С. Затем прибавл ют 100 мл этилалетата и смесь промывают 2 н. раствором карбоната натри и насыщенным pacTiBopOM хлорида натри . Органическую фазу отдел ют, высушивают над сульфатомat 20-25 ° C. Then 100 ml of ethyl acetate is added and the mixture is washed with 2N. sodium carbonate solution and saturated sodium chloride pacTiBopOM. The organic phase is separated, dried over sulfate.
натри И выпаривают. Остаток раствор ют в толуоле и фильтруют через колонку, налолненную 100 г сили-кагел . Фильтрат выларивают , лричем остаетс 2-1Пивалоилокси-2-(3пиридил )-ацетофенон, т. пл. 73-76° С, примгн емый далее без очистки.rub and evaporate. The residue is dissolved in toluene and filtered through a column of saturated 100 g of silica-gel. The filtrate is discharged, and 2-1Pivaloyloxy-2- (3-pyridyl) acetophenone remains as lyric, mp. 73-76 ° C, primed to be further without purification.
д)2-Трет-бутил-4-фенил-5- (3-пиридил) -оксазол .d) 2-tert-butyl-4-phenyl-5- (3-pyridyl) -oxazole.
Смесь 2,6 г (8,7 ммоль) 2-пивалоилокси-2 (З-лиридил)-ацетофенона, 50 г пивалиновой кислоты и 50 г аммониевой соли пивалиновой КИСЛОТЫ перемешивают 1 час при 110° С. Гор чий pacTiBop выливают в смесь .200 г льда и 180 мл концентрированного водного раствора аммиака и экс-црагируют метиленхлори.дом. Органическую фазу промывают концентрированным ВО.ДНЫМ раствором аммиака и насыщенным раствором хлорида натри , высушивают над сульфатом натри и выпаривают. Остаток хроматографируют 20-кратным количеством силикагел . Получают 2-г/7ег-бутил4-фенил-5- (3-лиридил)-оксазол iB виде масла.A mixture of 2.6 g (8.7 mmol) of 2-pavaloyloxy-2 (3-liridyl) acetophenone, 50 g of pivalic acid and 50 g of the ammonium salt of pivalic ACID is stirred at 110 ° C for 1 hour. The hot pacTiBop is poured into the mixture. 200 g of ice and 180 ml of a concentrated aqueous solution of ammonia and exgrated with methylene chloride. The organic phase is washed with concentrated W2N ammonia solution and saturated sodium chloride solution, dried over sodium sulfate and evaporated. The residue is chromatographed with a 20-fold amount of silica gel. Get 2-g / 7g-butyl4-phenyl-5- (3-lyridyl) -oxazole iB in the form of oil.
е)2-т/)ег.-Бутил-4(5)-фенил-5(4)-(3-пири дил )-и,мидазол.e) 2-t /) er. -butyl-4 (5) -phenyl-5 (4) - (3-pyr dil) -i, midazol.
Смесь 2,78 г (10 ммоль) 2-трет бутилАфенил-|5- (3-пиридил)-оксазола с 30 г жидкого аммиака и 21 г .формамида нагревают в автоклаве 5 -iac при 200 С. При этом давление вA mixture of 2.78 g (10 mmol) of 2-tert-butylAphenyl- 5- (3-pyridyl) -oxazole with 30 g of liquid ammonia and 21 g of formamide is heated in a 5 -iac autoclave at 200 C. At this pressure
автоклаве поднимаетс до 185 атм. После охлаждени смесь выливают в воду и экстрагируют этилацетатом. Орга ническую фазу отдел ют , промывают насыщенным раство.ром хлорида нат.ри до .нейтральной реакции, высушивают над сульфатом натр.и .и упаривают . Остаток раст1вор ют в смеси толуол- этилацетат (50: 50) и фильтруют через колонку , налолленную 50 г силикагел . Фильтрат упаривают и остаток перекристаллизовывают из толуола, лричем лолучают 2-трет-бутил-4 (5)-фенил-5(4)-(3-пиридил) - имидазол, т. пл. 188-189° С.autoclave rises to 185 atm. After cooling, the mixture is poured into water and extracted with ethyl acetate. The organic phase is separated, washed with a saturated solution of sodium chloride and neutralized, dried over sodium sulfate, and evaporated. The residue was diluted with toluene-ethyl acetate (50:50) and filtered through a column, saturated with 50 g of silica gel. The filtrate is evaporated and the residue is recrystallized from toluene, and 2-tert-butyl-4 (5) -phenyl-5 (4) - (3-pyridyl) -imidazole is obtained, and the pl. 188-189 ° C
Аналогично пункту 1е из 2-г/эет.-бутил-4 (/г-Л1етоксифенил)-5-(3-пиридил) - оксазола с аммиаком получают |2-грег.-бутил-4(5)-(г-метоксифенил )-5(4)-(3-пиридил) - имидазол, т. пл. 202-204° С (из толуола), а из 2-(«-хлорфеНИл )-4-(п-метоксифенил)-5-(3 - пиридил) оксазола - 2-(«-хлорфенил-4(5)-/г-метоксифгнил )-5(4)-(3-1Пир:идил)-имидазол, т. пл. 200-203° С.Similarly to paragraph 1e, from 2-g / eet.-butyl-4 (/ g-L1 methoxyphenyl) -5- (3-pyridyl) -oxazole with ammonia you get | 2-greg.-butyl-4 (5) - (g-methoxyphenyl ) -5 (4) - (3-pyridyl) - imidazole, so pl. 202-204 ° С (from toluene), and from 2 - ("- chlorophenyl) -4- (p-methoxyphenyl) -5- (3 - pyridyl) oxazole - 2 - (" - chlorophenyl-4 (5) - / g-methoxyfgnyl) -5 (4) - (3-1Pir: idyl) -imidazole, so pl. 200-203 ° C.
П р ИМ е р 2. К раствору 27,8 г (0,10 мтоль) 2-7/7ег.-бутил-4(5)-|фенил - 5(4)-(3-пиридил)имидазола в 900 мл ацетона црибавл ют при 20-25° С 9,61 г (6,5 мл 0,10 ммоль метансульфо кислоты ,и затем перемешивают час. Белые кристаллы фильтруют на нутчфильтре. После перекристаллизадии из смеси этанол-простой эфир полученный 3-г/7ег-бутил-4(5)-фенил-5(4) - (Знпиридил) имидазол-метансульфонат плавитс при 238- 240° С.P p mi e p 2. To a solution of 27.8 g (0.10 mtol) 2-7 / 7e.-butyl-4 (5) - | phenyl - 5 (4) - (3-pyridyl) imidazole in 900 ml acetone tsribavla at 20-25 ° C 9.61 g (6.5 ml of 0.10 mmol of methanesulfonic acid, and then stirred for an hour. The white crystals are filtered on a suction filter. After recrystallization from ethanol-ether, the resulting 3-g / 7g -butyl-4 (5) -phenyl-5 (4) - (Znpyridyl) imidazole-methanesulfonate melts at 238-240 ° C.
Claims (2)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH696771A CH561202A5 (en) | 1971-05-10 | 1971-05-11 | |
| CH425072A CH579072A5 (en) | 1971-05-10 | 1972-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU502605A3 true SU502605A3 (en) | 1976-02-05 |
Family
ID=25695022
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU1783894A SU456409A3 (en) | 1971-05-11 | 1972-05-10 | Method for preparing imidazole derivatives |
| SU1971711A SU502605A3 (en) | 1971-05-11 | 1973-11-27 | Method for preparing imidazole derivatives |
| SU1971712A SU489329A3 (en) | 1971-05-11 | 1973-11-27 | Method for preparing imidazole derivatives |
| SU1971713A SU489330A3 (en) | 1971-05-11 | 1973-11-27 | Method for preparing imidazole derivatives |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU1783894A SU456409A3 (en) | 1971-05-11 | 1972-05-10 | Method for preparing imidazole derivatives |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU1971712A SU489329A3 (en) | 1971-05-11 | 1973-11-27 | Method for preparing imidazole derivatives |
| SU1971713A SU489330A3 (en) | 1971-05-11 | 1973-11-27 | Method for preparing imidazole derivatives |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5630352B1 (en) |
| AR (4) | AR194594A1 (en) |
| CS (4) | CS181745B2 (en) |
| CY (1) | CY936A (en) |
| DD (1) | DD97654A5 (en) |
| ES (1) | ES402563A1 (en) |
| FI (1) | FI57407C (en) |
| HK (1) | HK61477A (en) |
| HU (1) | HU164884B (en) |
| IE (1) | IE36319B1 (en) |
| IL (1) | IL39285A (en) |
| KE (1) | KE2796A (en) |
| MY (1) | MY7800118A (en) |
| NO (1) | NO137445C (en) |
| PL (4) | PL92552B1 (en) |
| SU (4) | SU456409A3 (en) |
| YU (6) | YU35878B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY156539A (en) * | 2009-02-04 | 2016-02-26 | Otsuka Pharma Co Ltd | Phenylimidazole compounds |
-
1972
- 1972-04-18 FI FI108772A patent/FI57407C/en active
- 1972-04-24 IE IE53772A patent/IE36319B1/en unknown
- 1972-04-24 IL IL39285A patent/IL39285A/en unknown
- 1972-04-28 CY CY93672A patent/CY936A/en unknown
- 1972-05-09 PL PL17650972A patent/PL92552B1/en unknown
- 1972-05-09 PL PL17651072A patent/PL92549B1/en unknown
- 1972-05-09 ES ES402563A patent/ES402563A1/en not_active Expired
- 1972-05-09 PL PL17651272A patent/PL92546B1/en unknown
- 1972-05-09 PL PL15526372A patent/PL84726B1/en unknown
- 1972-05-10 HU HUCI001235 patent/HU164884B/hu unknown
- 1972-05-10 DD DD16286072A patent/DD97654A5/xx unknown
- 1972-05-10 SU SU1783894A patent/SU456409A3/en active
- 1972-05-10 NO NO166072A patent/NO137445C/en unknown
- 1972-05-10 JP JP4555472A patent/JPS5630352B1/ja active Pending
- 1972-05-10 YU YU123372A patent/YU35878B/en unknown
- 1972-05-11 CS CS596076A patent/CS181745B2/en unknown
- 1972-05-11 CS CS316372A patent/CS181711B2/en unknown
- 1972-05-11 AR AR24195372A patent/AR194594A1/en active
- 1972-05-11 CS CS596176A patent/CS181746B2/en unknown
- 1972-05-11 CS CS596276A patent/CS181747B2/en unknown
-
1973
- 1973-03-20 AR AR24713473A patent/AR195910A1/en active
- 1973-03-20 AR AR24713273A patent/AR198820A1/en active
- 1973-03-20 AR AR24713373A patent/AR198658A1/en active
- 1973-11-27 SU SU1971711A patent/SU502605A3/en active
- 1973-11-27 SU SU1971712A patent/SU489329A3/en active
- 1973-11-27 SU SU1971713A patent/SU489330A3/en active
-
1977
- 1977-11-15 KE KE279677A patent/KE2796A/en unknown
- 1977-12-08 HK HK61477A patent/HK61477A/en unknown
-
1978
- 1978-11-14 YU YU264678A patent/YU35881B/en unknown
- 1978-11-14 YU YU264478A patent/YU35879B/en unknown
- 1978-11-14 YU YU264578A patent/YU35880B/en unknown
- 1978-12-30 MY MY7800118A patent/MY7800118A/en unknown
-
1979
- 1979-04-09 YU YU83779A patent/YU35883B/en unknown
-
1980
- 1980-01-23 YU YU17680A patent/YU36165B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910007970B1 (en) | 4H-1-benzopyran-4-one derivatives or salts thereof, a process for their preparation and pharmaceutical compositions containing them as active ingredients | |
| US4810719A (en) | Anti-inflammator 1,n-diarylpyrazol-3-amines | |
| Haas et al. | The synthesis of pyridine derivatives from 3‐formylchromone | |
| JPH11508267A (en) | Pyrazole compounds and pharmaceutical compositions | |
| US4224445A (en) | Thienothiazine derivatives | |
| JP2004518641A (en) | Chemical methods and new intermediates | |
| US4767766A (en) | Derivatives of 3-hydroxyazabenzo(B)thiophene useful as 5-lipoxygenase inhibitors | |
| PL126032B1 (en) | Process for preparing novel derivatives of 5-phenyl-2-hydroxytetrahydrofuran | |
| US3784600A (en) | 4-substituted coumarins | |
| SU502605A3 (en) | Method for preparing imidazole derivatives | |
| SU475768A3 (en) | The method of obtaining (5-nitrofuryl-2) -pyridine | |
| US3444175A (en) | Certain picolylmethyl sulfones | |
| US4904672A (en) | Derivatives of 3-hydroxyazabenzo[b]thiophene useful as 5-lipoxygenase inhibitors | |
| SU591149A3 (en) | Method of preparing derivatives of triazoloisoquinoline | |
| SU442601A1 (en) | Method for producing azepine derivatives | |
| US3438992A (en) | Certain lower-alkyl sulfinylmethyl pyridines | |
| NO159276B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE IMIDAZO (1,5-A) PYRIDINES. | |
| SU692561A3 (en) | Method of preparing 2-nitro-8-phenylbenzofuran derivatives | |
| US5574033A (en) | Heterocyclic compound and cardiotonic agent containing the same as effective component | |
| NO751594L (en) | ||
| US5457201A (en) | Chiral resolution process | |
| US4202977A (en) | S-Triazolo [1,5-a] pyridine derivatives | |
| US3551444A (en) | Lower alkyl sulfinyl methyl imidazoles | |
| JPS6350351B2 (en) | ||
| KR0156327B1 (en) | Benz or pyrimidimidazole derivatives |